Singulair Related Published Studies
Well-designed clinical trials related to Singulair (Montelukast)
Can Montelukast Shorten Prednisolone Therapy in Children with Mild to Moderate Acute Asthma? A Randomized Controlled Trial. [2009.08.03]
A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma. [2009.06]
Single-dose desloratadine and montelukast and allergen-induced late airway responses. [2009.06]
Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics. [2009.05.11]
Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial). [2009.05]
Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): an open-label effectiveness trial. [2009.05]
Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial). [2009.05]
Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit. [2009.05]
Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion. [2009.05]
The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity. [2009.05]
Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit. [2009.04]
Effect of montelukast on excessive airway narrowing response to methacholine in adult asthmatic patients not on controller therapy. [2009.01]
Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study. [2009]
A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis. [2008.12]
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. [2008.12]
A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis. [2008.12]
Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis. [2008.11]
Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. [2008.10.15]
Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial. [2008.10]
Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients. [2008.09]
Anti-IgE Antibody Therapy for Japanese Cedar Pollinosis: Omalizumab Update. [2008.09]
Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. [2008.08]
Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial. [2008.07.02]
Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. [2008.06]
Efficacy of montelukast and loratadine as treatment for allergic rhinitis in children. [2008.06]
Efficacy of levocetirizine compared with montelukast in subjects with ragweed-induced seasonal allergic rhinitis in the Environmental Exposure Unit. [2008.05]
Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis. [2008.04]
Effects of exercise training and montelukast in children with mild asthma. [2008.03]
Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years. [2008.01]
Effect of azelastine, montelukast, and their combination on allergen-induced bronchoconstriction in asthma. [2008]
Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. [2008]
A double-blind, placebo-controlled trial of montelukast in adult atopic eczema. [2007.10]
Montelukast vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial. [2007.10]
Montelukast for treatment of refractory pruritus in patients on hemodialysis. [2007.10]
Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma. [2007.09.27]
Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. [2007.09]
Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction. [2007.09]
Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children. [2007.09]
The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. [2007.09]
Montelukast treatment in children with moderately severe atopic dermatitis. [2007.09]
Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control. [2007.08]
Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide. [2007.08]
Single-Dose Montelukast or Salmeterol as Protection Against Exercise-Induced Bronchoconstriction. [2007.07.23]
Montelukast vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial. [2007.07.10]
Montelukast as add-on therapy to beta-agonists and late airway response. [2007.07]
Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis. [2007.06]
Efficacy of montelukast for treating perennial allergic rhinitis. [2007.05]
Short-course montelukast for intermittent asthma in children: a randomized controlled trial. [2007.02.15]
Premedication with montelukast reduces local reactions of allergen immunotherapy. [2007]
Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis. [2006.12]
Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. [2006.12]
Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study. [2006.12]
Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. [2006.11]
Clinical Trial of Low-Dose Theophylline and Montelukast in Patients with Poorly Controlled Asthma. [2006.09.22]
Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial. [2006.09]
Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. [2006.09]
A randomized open-label comparative study of montelukast versus theophylline added to inhaled corticosteroid in asthmatic children. [2006.09]
Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children. [2006.08]
Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. [2006.07]
Montelukast improves pulmonary function measured by impulse oscillometry in children with asthma (Mio study). [2006.07]
Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. [2006.06]
Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study. [2006.06]
Pharmacokinetics and safety of montelukast in children aged 3 to 6 months. [2006.06]
Oral montelukast treatment of preschool-aged children with acute asthma. [2006.05]
Effect of montelukast on peripheral airflow obstruction in children with asthma. [2006.04]
Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide. [2006.03]
Montelukast administered in the morning or evening to prevent exercise-induced bronchoconstriction in children. [2006.03]
Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. [2006.02]
Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. [2006.02]
Montelukast improves regional air-trapping due to small airways obstruction in asthma. [2006.02]
Effectiveness of montelukast in the treatment of atopic dermatitis. [2006.01]
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. [2006.01]
Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. [2005.12]
Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis. [2005.10]
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. [2005.10]
Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen. [2005.10]
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves. [2005.08]
Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma. [2005.08]
Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. [2005.08]
Montelukast versus formoterol as second-line therapy in asthmatic children exposed to relevant allergens. [2005.07]
[Montelukast: new therapeutic option in patients with nasal polyps associated to respiratory allergic disease] [2005.07]
Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial. [2005.07]
Tapering dose of inhaled budesonide in subjects with mild-to-moderate persistent asthma treated with montelukast: a 16-week single-blind randomized study. [2005.06]
Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma. [2005.06]
Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial. [2005.06]
Comparative effects of fexofenadine and montelukast on allergen-induced wheal and flare. [2005.05]
A population pharmacokinetic model for montelukast disposition in adults and children. [2005.04]
Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise. [2005.04]
Short-term effects of montelukast in stable patients with moderate to severe COPD. [2005.04]
The effect of montelukast on eosinophil apoptosis: induced sputum findings of patients with mild persistent asthma. [2005.03]
Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. [2005.02.15]
Bronchoconstriction provoked by exercise in a high-particulate-matter environment is attenuated by montelukast. [2005.02]
Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. [2005.02]
The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. [2005.02]
Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast. [2005.02]
Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens. [2005.02]
Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction. [2005.02]
Effect of a single dose of montelukast sodium on methacholine chloride PC20. [2005.01]
Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma. [2005.01]
Differential effects of fluticasone and montelukast on allergen-induced asthma. [2005.01]
The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma. [2005]
|
